Cargando…

Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals

Brain serotonergic (5-HT) signaling is posited to modulate neural responses to emotional stimuli. Dysfunction in 5-HT signaling is implicated in major depressive disorder (MDD), a disorder associated with significant disturbances in emotion processing. In MDD, recent evidence points to altered 5-HT(...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sankar, Anjali, Ozenne, Brice, Dam, Vibeke H., Svarer, Claus, Jørgensen, Martin B., Miskowiak, Kamilla W., Frokjaer, Vibe G., Knudsen, Gitte M., Fisher, Patrick M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175268/ https://www.ncbi.nlm.nih.gov/pubmed/37169780 http://dx.doi.org/10.1038/s41398-023-02440-3

Ejemplares similares

Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders
por: Sankar, Anjali, et al.
Publicado: (2023)

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study
por: Köhler-Forsberg, Kristin, et al.
Publicado: (2022)

Brain serotonin transporter is associated with cognitive‐affective biases in healthy individuals
por: Armand, Sophia, et al.
Publicado: (2022)

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study
por: Larsen, Søren Vinther, et al.
Publicado: (2022)

Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study
por: Vulpius, Gunild M, et al.
Publicado: (2023)

Genetic contributions to brain serotonin transporter levels in healthy adults
por: Bruzzone, Silvia Elisabetta Portis, et al.
Publicado: (2023)

Brain serotonin 4 receptor binding is inversely associated with verbal memory recall
por: Stenbæk, Dea S., et al.
Publicado: (2017)

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
por: Köhler-Forsberg, Kristin, et al.
Publicado: (2020)

Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
por: Larsen, S. V., et al.
Publicado: (2020)

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
por: Dam, Vibeke Høyrup, et al.
Publicado: (2022)

Visual stimuli induce serotonin release in occipital cortex: A simultaneous positron emission tomography/magnetic resonance imaging study
por: Hansen, Hanne Demant, et al.
Publicado: (2020)

Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users
por: Høgsted, Emma Sofie, et al.
Publicado: (2021)

Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort
por: Jensen, Kristian Høj Reveles, et al.
Publicado: (2023)

BDNF val66met association with serotonin transporter binding in healthy humans
por: Fisher, P M, et al.
Publicado: (2017)

Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
por: Beliveau, Vincent, et al.
Publicado: (2022)

Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression—a NeuroPharm study
por: Rasmussen, Annika Læbo, et al.
Publicado: (2023)

Default mode network functional connectivity negatively associated with trait openness to experience
por: Marstrand-Joergensen, Maja Rou, et al.
Publicado: (2021)

Common HTR2A variants and 5‐HTTLPR are not associated with human in vivo serotonin 2A receptor levels
por: Spies, Marie, et al.
Publicado: (2020)

No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study
por: Stenbæk, Dea Siggaard, et al.
Publicado: (2017)

Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial
por: Høgh, Stinne, et al.
Publicado: (2021)

Brain Networks Implicated in Seasonal Affective Disorder: A Neuroimaging PET Study of the Serotonin Transporter
por: Nørgaard, Martin, et al.
Publicado: (2017)

Psychometric Properties and Validation of the EMOTICOM Test Battery in a Healthy Danish Population
por: Dam, Vibeke H., et al.
Publicado: (2019)

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder
por: Hjordt, Liv V., et al.
Publicado: (2020)

Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age
por: Sundström Poromaa, Inger, et al.
Publicado: (2019)

Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals
por: Søndergaard, Anna, et al.
Publicado: (2022)

Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females
por: Tuominen, Lauri, et al.
Publicado: (2017)

Eye gaze and facial displays of emotion during emotional film clips in remitted patients with bipolar disorder
por: Kjærstad, Hanne Lie, et al.
Publicado: (2020)

The longitudinal trajectory of emotion regulation and associated neural activity in patients with bipolar disorder: A prospective fMRI study
por: Kjærstad, Hanne Lie, et al.
Publicado: (2022)

Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication
por: Conradi, Juliane, et al.
Publicado: (2023)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
por: Baltzersen, Olga B., et al.
Publicado: (2020)

Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression
por: Jorgensen, Anders, et al.
Publicado: (2022)

Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals
por: McCulloch, Drummond E-Wen, et al.
Publicado: (2021)

Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study
por: Dam, V. H., et al.
Publicado: (2021)

Effects of recombinant human erythropoietin on cognition and neural activity in remitted patients with mood disorders and first-degree relatives of patients with psychiatric disorders: a study protocol for a randomized controlled trial
por: Petersen, Jeff Zarp, et al.
Publicado: (2018)

Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation
por: Burmester, Daniel Rødbro, et al.
Publicado: (2022)

Familial Risk for Major Depression is Associated with Lower Striatal 5-HT(4) Receptor Binding
por: Madsen, Karine, et al.
Publicado: (2014)

Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial
por: Ott, Caroline V., et al.
Publicado: (2018)

Correction to: Effect of action-based cognitive remediation on cognition and neural activity in bipolar disorder: study protocol for a randomized controlled trial
por: Ott, Caroline V., et al.
Publicado: (2019)

The serotonin transporter gene polymorphism and the effect of baseline on amygdala response to emotional faces
por: von dem Hagen, Elisabeth A.H., et al.
Publicado: (2011)

Pharmacological sex hormone manipulation as a risk model for depression
por: Frokjaer, Vibe G.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_us0k2tl4duhd8vom4kqhretl9d